Nulojix®
Nulojix® (belatacept) is a selective T cell co-stimulation blocker. It is used with other drugs to prevent kidney transplant rejection. Nulojix® works by weakening the body’s immune system to help prevent rejection.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
WHAT IT TREATS: |
MANUFACTURER: Bristol Myers Squibb |
CLASS: T Cell Blocker |
PRESCRIBED BY: Nephrologists (kidney doctors) |
HOW ADMINISTERED: IV infusion |
FREQUENCY: Day one, day five, week two, week four then every four weeks |
Length of infusion: About 30 mins |
FOR MORE INFORMATION: |
